Enterococcus faecium Bacteremia
Open Access
- 9 March 1998
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 158 (5) , 522-527
- https://doi.org/10.1001/archinte.158.5.522
Abstract
ENTEROCOCCUS faecium has grown in importance as a nosocomial pathogen during the past decade.1,2 While there once was controversy regarding the pathogenic role of enterococci in causing infection, mounting evidence has now established E faecium as a cause of significant morbidity and mortality in hospitalized patients who are infected with this organism.3-6 Notorious for resistance to multiple antimicrobial agents, the acquisition of vancomycin resistance has made this organism a formidable pathogen.This publication has 10 references indexed in Scilit:
- Differences in Outcomes for Patients with Bacteremia Due to Vancomycin-Resistant Enterococcus faecium or Vancomycin-Susceptible E. faeciumClinical Infectious Diseases, 1996
- The challenge of vancomycin-resistant enterococci: A clinical and epidemiologic studyAmerican Journal of Infection Control, 1995
- Enterococcus faecium and Enterococcus faecalis Bacteremia: Acquisition and OutcomeClinical Infectious Diseases, 1995
- Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unitAntimicrobial Agents and Chemotherapy, 1994
- Emergence of vancomycin-resistant enterococci in New York CityThe Lancet, 1993
- Emergence of Enterococcus as a Significant PathogenClinical Infectious Diseases, 1992
- Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during TherapyAnnals of Internal Medicine, 1991
- Resistance of Enterococcus faecium to vancomycin and gentamicinThe Lancet, 1991
- The enterococci: Evidence of species-specific clinical and microbiologic heterogeneityThe Lancet Healthy Longevity, 1989
- Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus FaeciumNew England Journal of Medicine, 1988